Brien Holden Teams with Contamac to Develop Contact Lenses for Myopia Control
Tuesday, February 3 2015 | 00 h 00 min | Agreements and Partnerships
Contamac, UK global provider of biocompatible materials for the ophthalmic industry and the Brien Holden Institute announced a partnership to develop gas permeable and silicone hydrogel contact lens products (CLs) focused on myopia control. The goal is to commercialize specialized CLs designs that reduce myopia progression in children.
“This is an important step in making effective myopia control technologies available to reduce the rate of progress of myopia and the risk of permanent vision impairment associated with high levels of myopia later in life,” said Professor Brien Holden, CEO of the Brien Holden Vision Institute.
Contamac indicates that the number of eye care professionals using CLs to control myopia is rising and interest in specialty contacts is growing rapidly. Martin Dalsing, Contamac’s Director of Global Strategy and Business said, “Making available these specialized custom lens parameters and designs to the eye care professional through our laboratory network will be crucial for today’s modern specialty contact lens practice.”